NCT07087301View on ClinicalTrials.gov

Vancomycin Concentration Analysis in Post-Cardiac Surgery Patients

CompletedOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Cardiac Surgery Requiring Cardiopulmonary Bypass
Interventions
OTHER

subtherapeutic concentration risk group

The second model (for subtherapeutic concentration risk prediction) defined low concentration as trough \<10 mg/L and target as 10-20 mg/L to analyze predictors of target concentration attainment.

DRUG

subtherapeutic concentration risk group

The second model (for subtherapeutic concentration risk prediction) defined low concentration as trough \<10 mg/L and target as 10-20 mg/L to analyze predictors of target concentration attainment.

Trial Locations (1)

450046

Fuwai Central China Cardiovascular Hospital, Zhengzhou

All Listed Sponsors
lead

Pengqiang Du

OTHER